These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22560886)

  • 41. Prospective study of Chironex fleckeri and other box jellyfish stings in the "Top End" of Australia's Northern Territory.
    Currie BJ; Jacups SP
    Med J Aust; 2005 Dec 5-19; 183(11-12):631-6. PubMed ID: 16336157
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Jellyfish envenoming syndromes: unknown toxic mechanisms and unproven therapies.
    Bailey PM; Little M; Jelinek GA; Wilce JA
    Med J Aust; 2003 Jan; 178(1):34-7. PubMed ID: 12492389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolation and in vitro partial characterization of hemolytic proteins from the nematocyst venom of the jellyfish Stomolophus meleagris.
    Li R; Yu H; Xing R; Liu S; Qing Y; Li K; Li B; Meng X; Cui J; Li P
    Toxicol In Vitro; 2013 Sep; 27(6):1620-5. PubMed ID: 23603477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purification of Chironex fleckeri venom components using Chironex immunoaffinity chromatography.
    Naguib AM; Bansal J; Calton GJ; Burnett JW
    Toxicon; 1988; 26(4):387-94. PubMed ID: 2900563
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimization and preliminary characterization of venom isolated from 3 medically important jellyfish: the box (Chironex fleckeri), Irukandji (Carukia barnesi), and blubber (Catostylus mosaicus) jellyfish.
    Wiltshire CJ; Sutherland SK; Fenner PJ; Young AR
    Wilderness Environ Med; 2000; 11(4):241-50. PubMed ID: 11199528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Marine antivenoms.
    Currie BJ
    J Toxicol Clin Toxicol; 2003; 41(3):301-8. PubMed ID: 12807313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aquatic antagonists: Cubozoan jellyfish (Chironex fleckeri and Carukia barnesi).
    Ottuso PT
    Cutis; 2010 Mar; 85(3):133-6. PubMed ID: 20408511
    [No Abstract]   [Full Text] [Related]  

  • 48. The effectiveness of antivenom in countering the actions of box-jellyfish (Chironex fleckeri) nematocyst toxins in mice.
    Endean R; Sizemore DJ
    Toxicon; 1988; 26(5):425-31. PubMed ID: 2903586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular dissection of box jellyfish venom cytotoxicity highlights an effective venom antidote.
    Lau MT; Manion J; Littleboy JB; Oyston L; Khuong TM; Wang QP; Nguyen DT; Hesselson D; Seymour JE; Neely GG
    Nat Commun; 2019 Apr; 10(1):1655. PubMed ID: 31040274
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A rapid and repeatable method for venom extraction from cubozoan nematocysts.
    Carrette T; Seymour J
    Toxicon; 2004 Aug; 44(2):135-9. PubMed ID: 15246760
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of allergens in the box jellyfish Chironex yamaguchii that cause sting dermatitis.
    Horiike T; Nagai H; Kitani S
    Int Arch Allergy Immunol; 2015; 167(2):73-82. PubMed ID: 26201970
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isolation and characterization of lethal proteins in nematocyst venom of the jellyfish Cyanea nozakii Kishinouye.
    Feng J; Yu H; Li C; Xing R; Liu S; Wang L; Cai S; Li P
    Toxicon; 2010 Jan; 55(1):118-25. PubMed ID: 19619571
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular actions of the venom from the Irukandji (Carukia barnesi) jellyfish: effects in human, rat and guinea-pig tissues in vitro and in pigs in vitro.
    Winkel KD; Tibballs J; Molenaar P; Lambert G; Coles P; Ross-Smith M; Wiltshire C; Fenner PJ; Gershwin LA; Hawdon GM; Wright CE; Angus JA
    Clin Exp Pharmacol Physiol; 2005 Sep; 32(9):777-88. PubMed ID: 16173936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isolation, Structure Determination, and Synthesis of Cyclic Tetraglutamic Acids from Box Jellyfish Species
    Reinicke J; Kitatani R; Masoud SS; Galbraith KK; Yoshida W; Igarashi A; Nagasawa K; Berger G; Yanagihara A; Nagai H; Horgen FD
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32079282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo effects of cnidarian toxins and venoms.
    Suput D
    Toxicon; 2009 Dec; 54(8):1190-200. PubMed ID: 19281834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of antivenom and verapamil on the haemodynamic actions of Chironex fleckeri (box jellyfish) venom.
    Tibballs J; Williams D; Sutherland SK
    Anaesth Intensive Care; 1998 Feb; 26(1):40-5. PubMed ID: 9513666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Response of the box-jellyfish (Chironex fleckeri) cardiotoxin to intravenous administration of verapamil.
    Burnett JW; Calton GJ
    Med J Aust; 1983 Aug; 2(4):192-4. PubMed ID: 6135976
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Venom ontogeny, diet and morphology in Carukia barnesi, a species of Australian box jellyfish that causes Irukandji syndrome.
    Underwood AH; Seymour JE
    Toxicon; 2007 Jun; 49(8):1073-82. PubMed ID: 17395227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence for an Alternative Mechanism of Toxin Production in the Box Jellyfish Alatina alata.
    Lewis Ames C; Macrander J
    Integr Comp Biol; 2016 Nov; 56(5):973-988. PubMed ID: 27880678
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Techniques applicable for purifying Chironex fleckeri (box-jellyfish) venom.
    Othman I; Burnett JW
    Toxicon; 1990; 28(7):821-35. PubMed ID: 1977211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.